Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Poseida Therapeutics Appoints Five New Members to Its Gene Therapy Scientific Advisory Board
Poseida Therapeutics, a clinical-stage cell and gene therapy company advancing a new class of treatments […]
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a […]
AlloVir Appoints Derek Adams, Ph.D., to Board of Directors
AlloVir, a late-clinical stage allogeneic T cell immunotherapy company, today announced the appointment of Derek […]
Phio Pharmaceuticals Appoints Robert Bitterman as President and Chief Executive Officer
Phio Pharmaceuticals, a clinical-stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to […]
Radionetics Oncology Appoints Istvan Molnar, M.D. as Chief Medical Officer
Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for […]
Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
Heron Therapeutics, a commercial-stage biotechnology company focused on improving the lives of patients by developing […]
CLEARA Biotech Appoints Nicholas J. Sarlis, MD, PhD as Chief Medical Officer and Head of Clinical Development
CLEARA Biotech, a preclinical-stage biotechnology company focused on developing innovative, proprietary therapies for treating different […]
C4XD and Garvan Institute of Medical Research Report Successful Patient Stratification Approach Using C4XD's New Precision Medicine Platform PatientSeek
C4X Discovery Holdings (C4XD), a pioneering Drug Discovery company, announces the launch of a precision […]
Medivir Announces Pia Baumann as Chief Medical Officer (CMO)
Medivir AB, a pharmaceutical company focused on developing innovative treatments for cancer in areas of […]
Life Line Screening Appoints Matt Miller as Chief Executive Officer
Life Line Screening, a leading mobile preventative health screening company, announces the appointment of Matt […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more